Acción INTELLIPHARMACEUTICS INTERNATIONAL INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas IntelliPharmaCeutics International Inc. OTC Bulletin Board

Acciones

CA4581733090

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Canadian Investment Regulatory Organization Trading Halt - IPCI
IntelliPharmaCeutics International Receives Conditional Approval For TSXV Listing
Intellipharmaceutics: Fiscal Q3 Earnings Snapshot
Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 - Form 6-K
Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023
Intellipharmaceutics International : Reports Director Election Results - Form 6-K
Intellipharmaceutics International : Appointment of Proxyholder - Form 6-K
Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K
Intellipharmaceutics Announces Second Quarter 2023 Results
Intellipharmaceutics International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023
Intellipharmaceutics: Fiscal Q2 Earnings Snapshot
IntelliPharmaCeutics International Fiscal Q2 Loss Narrows on Higher Revenue
Canadian Investment Regulatory Organization Trade Resumption - IPCI
Intellipharmaceutics: Fiscal Q4 Earnings Snapshot
Intellipharmaceutics: Fiscal Q1 Earnings Snapshot
Intellipharmaceutics International Narrows Fiscal Q1 Loss, Revenue Rises
Intellipharmaceutics International Inc. Brief: Recorded net loss for Q1 of US$355,738 or $0.01 per common shar
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results
Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt
Intellipharmaceutics International Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción IPCI.H
  4. Acción
  5. Noticias IntelliPharmaCeutics International Inc.
  6. Otros idiomas